Results 141 to 150 of about 158,369 (302)
Clinical Validation of Plasma p‐217tau in Neurological Diseases
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
Quantum corrections to the effective neutrino mass operator in 5D MSSM
30 pages, 10 figures - TheorieInternational audienceWe discuss in detail a five-dimensional Minimal Supersymmetric Standard Model compactified on S^1/Z_2 extended by the effective Majorana neutrino mass operator. We study the evolution of neutrino masses
Deandrea, Aldo +3 more
core +1 more source
Mathematical Analysis of a Generalized Chiral Quark Soliton Model
A generalized version of the so-called chiral quark soliton model (CQSM) in nuclear physics is introduced. The Hamiltonian of the generalized CQSM is given by a Dirac type operator with a mass term being an operator-valued function.
Asao Arai
doaj
Predictive Ability of Plasma p‐tau217 for β‐Amyloid Status: A Prospective Multicenter Study
ABSTRACT Objective Plasma tau phosphorylated at threonine 217 (p‐tau217) measured with fully automated platforms has shown high accuracy for Alzheimer's disease (AD) diagnosis, but real‐world multicenter data remain limited. We aimed to validate the diagnostic performance of p‐tau217 for identifying AD pathology in a real‐world multicenter cohort ...
Miquel Massons +33 more
wiley +1 more source
The non-perturbative QCD Debye mass from a Wilson line operator
Laine M, Philipsen O. The non-perturbative QCD Debye mass from a Wilson line operator. Physics Letters B. 1999;459(1-3):259-264.According to a proposal by Arnold and Yaffe, the non-perturbative g(2)T-contribution to the Debye mass in the deconfined QCD ...
Laine, Mikko ; https://orcid.org/ +3 more
core +1 more source
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi +9 more
wiley +1 more source
Recurrent Hypothermia and Autonomic Dysfunction Secondary to Shapiro Syndrome
ABSTRACT A 44‐year‐old man presented with recurrent hypothermia, diaphoresis and hypertension. Extensive investigation for infectious, inflammatory, metabolic and endocrine aetiologies was negative. MR scan of the brain demonstrated no lesions but revealed callosal dysgenesis, consistent with Shapiro syndrome.
Naveen Kumar +3 more
wiley +1 more source
The three loop anomalous dimension for the gauge invariant, renormalizable, non-local mass operator for a gluon is computed in the MS¯ scheme. In addition the anomalous dimensions of the associated localizing ghost fields are also deduced at the same ...
Gracey, J.A., Ford, F.R.
core +1 more source
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source

